Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment
Ended Awarded
- Contract number
- HT009025FG0710073
- Awardee
-
Sofie CO. UEI JV1AHJHGUGG3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $14,435
Award facts
- Contract value 100% obligated
- $14,434.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $14,434.88 firm fixed-price contract call to Sofie CO. (doing business as IBA Molecular) on June 24, 2025, for the provision of radiopharmaceuticals needed to treat prostate cancer patients with metastatic lesions following definitive treatment. The contract will be performed in Sterling, Virginia, and is scheduled for completion by September 30, 2025. This task order was issued under an existing Blanket Purchase Agreement and carries no set-aside designation, reflecting Sofie CO.'s competitive standing as a specialized supplier of positron emission tomography imaging agents and radiopharmaceutical products to federal healthcare agencies.
Sofie CO. is a subsidiary of Sofie Biosciences, Inc., headquartered in Sterling, Virginia, and specializes in the development and delivery of molecular diagnostics and therapeutics for cancer detection and neurological imaging. The company maintains substantial existing vehicles with the Defense Health Agency and Department of Veterans Affairs, including a $6.5 million blanket purchase agreement for radiopharmaceuticals. Under these agreements, Sofie CO. delivers critical imaging products such as PYLARIFY (fluorine-18 DCFPYL) for prostate cancer detection, supporting medical treatment facilities serving both military personnel and veterans across the federal healthcare system.
Quick answers
Who was awarded contract HT009025FG0710073?
HT009025FG0710073 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on June 24, 2025.
How much is contract HT009025FG0710073 worth?
The government has obligated $14,435 on HT009025FG0710073.
Is contract HT009025FG0710073 an order under another contract?
Yes. HT009025FG0710073 is a BPA call under HT001424A0002, a blanket purchase agreement.
Was contract HT009025FG0710073 competed?
The extent of competition for HT009025FG0710073 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award